This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Colorectal cancer is the fourth leading cause of cancer-related deaths worldwide. This relatively poor survival results, in part, due to genetic changes during the development of colorectal cancer that reduce the ability of tumor cells to undergo apoptosis (programmed cell death) and cause resistance to chemotherapy. Recent evidence has demonstrated that the Raf kinase inhibitory protein (RKIP) is an effector of chemotherapy-triggered apoptosis and metastasis suppressor in human cancers. As opposed to RKIP, signal-transducer-and-activator-of-transcription-3 (STAT3) is an oncogene that inhibits apoptosis and promotes tumor formation and metastasis in human colon cancer. Inhibitors of STAT3 have been proposed for colon cancer therapy. We have taken two approaches to determine if RKIP protein level is predictive of colon cancer patient survival and if RKIP can inhibit STAT3-triggered colon cancer metastasis. In the first, we are analyzing the expression of RKIP and STAT3 in 160 biopsied colon cancer tumor tissues. We will correlate the expression of RKIP and STAT3 with patient survival over a 5 year period. In our second approach, we have genetically created 7 human colon cancer cell lines to determine if the expression of RKIP can block STAT3 triggered metastasis. These cell lines will differ in the expression of STAT3 and RKIP (high vs none) with various combinations. We are now prepared to inoculate the 7 cell lines into mice and monitor the movement of the colon tumor cells to distal organs (i.e., lung, liver). Our hypothesis is that RKIP will block STAT3-triggered metastasis.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR017695-08
Application #
8359713
Study Section
Special Emphasis Panel (ZRR1-RI-B (01))
Project Start
2011-05-01
Project End
2012-04-30
Budget Start
2011-05-01
Budget End
2012-04-30
Support Year
8
Fiscal Year
2011
Total Cost
$225,197
Indirect Cost
Name
Rhode Island Hospital
Department
Type
DUNS #
075710996
City
Providence
State
RI
Country
United States
Zip Code
02903
Lopez, Chelsea E; Sheehan, Hannah C; Vierra, David A et al. (2017) Proteomic responses to elevated ocean temperature in ovaries of the ascidian Ciona intestinalis. Biol Open 6:943-955
Francois-Vaughan, Heather; Adebayo, Adeola O; Brilliant, Kate E et al. (2016) Persistent effect of mTOR inhibition on preneoplastic foci progression and gene expression in a rat model of hepatocellular carcinoma. Carcinogenesis 37:408-419
Li, Ming; Tucker, Lynne D; Asara, John M et al. (2016) Stem-loop binding protein is a multifaceted cellular regulator of HIV-1 replication. J Clin Invest 126:3117-29
Breen, Lucas D; Pu?i?-Bakovi?, Maja; Vu?kovi?, Frano et al. (2016) IgG and IgM glycosylation patterns in patients undergoing image-guided tumor ablation. Biochim Biophys Acta 1860:1786-94
Mulvey, Hillary E; Chang, Audrey; Adler, Jason et al. (2015) Extracellular vesicle-mediated phenotype switching in malignant and non-malignant colon cells. BMC Cancer 15:571
Cheng, Yan; Holloway, Michael P; Nguyen, Kevin et al. (2014) XPO1 (CRM1) inhibition represses STAT3 activation to drive a survivin-dependent oncogenic switch in triple-negative breast cancer. Mol Cancer Ther 13:675-86
Yousuf, Saad; Duan, MeiLi; Moen, Erika L et al. (2014) Raf kinase inhibitor protein (RKIP) blocks signal transducer and activator of transcription 3 (STAT3) activation in breast and prostate cancer. PLoS One 9:e92478
Cao, Weibiao; Tian, Wei; Hong, Jie et al. (2013) Expression of bile acid receptor TGR5 in gastric adenocarcinoma. Am J Physiol Gastrointest Liver Physiol 304:G322-7
Panagopoulos, Kiriaki; Cross-Knorr, Sam; Dillard, Christen et al. (2013) Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure. Mol Cancer 12:118
Perez, K; Walsh, R; Brilliant, K et al. (2013) Heterogeneity of colorectal cancer (CRC) in reference to KRAS proto-oncogene utilizing WAVE technology. Exp Mol Pathol 95:74-82

Showing the most recent 10 out of 126 publications